DENNIS LANGER
CIK 1274225 · last filed 2026-02-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$760.5K
Companies
10
Total Filings
70
Lifetime Open-Market Net
-$10.51M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNRX | Director | 15,153 | $4.20 | $63.6K | $128.4K | 7 | 2026-02-06 |
| MYGN | Director | 106,802 | $4.33 | $462.5K | -$9.94M | 26 | 2022-06-30 |
| BTX | Director | — | $9.03 | — | $0 | 1 | 2021-12-10 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 77,042 | $38.22 | $2.94M | -$697.1K | 11 | 2019-06-21 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 3 | 2018-05-23 |
| DCTH | Director | 20,000 | $11.72 | $234.4K | $0 | 2 | 2015-06-12 |
| Myrexis, Inc. (MYRX) Delisted | Director | — | — | — | $0 | 3 | 2011-12-12 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 1,366 | — | — | $0 | 13 | 2010-06-07 |
| CYTOGEN CORP (CYTO) Delisted | Director | 0 | $0.30 | $0 | $0 | 2 | 2008-05-09 |
| PHARMACOPEIA INC (PCOP) Delisted | Director | — | — | — | $0 | 1 | 2008-05-02 |
Recent Filings · Page 3 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-01 | MYGN | Mixed | — | -$135.3K | EDGAR |
| 2018-05-23 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | MYGN | Mixed | — | -$115.1K | EDGAR |
| 2018-01-30 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Exer (M) | +360 | $1.2K | EDGAR |
| 2017-11-30 | MYGN | Grant (A) | +7,219 | $0 | EDGAR |
| 2017-11-17 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-20 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-01 | MYGN | Grant (A) | +15,024 | $0 | EDGAR |
| 2016-11-17 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −23,766 | -$83.7K | EDGAR |
| 2016-11-08 | PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.